Clinical Trial

Gluteal Activation Plus Movement Retraining

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 16, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine if an isometric gluteal activation home exercise program (HEP) combined with a movement retraining program utilizing feedback cues produces significant changes in scores on the Forward Step-Down Test (FSDT) in healthy young adults with movement coordination impairments. Aim 1: To determine if an isometric gluteal activation HEP with a movement retraining program with feedback cues produces significant changes on scores FSDT compared to the gluteal activation HEP alone. Aim 2: To determine if an isometric gluteal activation HEP followed with a movement retraining program with feedback cues produces significant changes on category FSDT compared to gluteal activation HEP alone. Aim 3: To determine if an isometric gluteal activation HEP with a movement retraining program with feedback cues produces changes in the peak activation of the gluteus medius (GMed) and gluteus maximus (GMax) during the FSDT compared to the gluteal activation HEP alone. Aim 4: To determine if an isometric gluteal activation HEP with a movement retraining program with feedback cues produces changes in the mean activation of the GMed and GMax during the FSDT compared to the gluteal activation HEP alone. Aim 5: To determine if HEP dose has an effect on the FSDT response, as measured by change in score on the FSDT.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-15.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-01-14
Trial Details
NCT Number NCT07293039
Lead Sponsor Louisiana State University Health Sciences Center Shreveport
Conditions Movement, Abnormal, Lower Extremity Problem
Enrollment 38 participants
Start Date 2026-01-07
Primary Completion 2026-04 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-01-16